专科医生对处方药非医疗转换的看法。

Q2 Medicine Journal of market access & health policy Pub Date : 2020-03-09 eCollection Date: 2020-01-01 DOI:10.1080/20016689.2020.1738637
Olivia S Costa, Tabassum Salam, Amy Duhig, Aarti A Patel, Ann Cameron, Jennifer Voelker, Brahim Bookhart, Craig I Coleman
{"title":"专科医生对处方药非医疗转换的看法。","authors":"Olivia S Costa,&nbsp;Tabassum Salam,&nbsp;Amy Duhig,&nbsp;Aarti A Patel,&nbsp;Ann Cameron,&nbsp;Jennifer Voelker,&nbsp;Brahim Bookhart,&nbsp;Craig I Coleman","doi":"10.1080/20016689.2020.1738637","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction</b>: A non-medical switch is a change to a patient's medication regimen for reasons other than lack of clinical response, side-effects or poor adherence. Specialist physicians treat complex patients who may be vulnerable to non-medical switching. <b>Objectives</b>: To evaluate specialist physicians' perceptions regarding the frequency of non-medical switch requests, and the impact on their patients' outcomes and healthcare utilization. <b>Methods</b>: An online survey of randomly sampled physicians spending ≥10% of time providing patient care and having received ≥1 non-medical switch request during the prior 12-months. <b>Results</b>: Among 404 specialist physicians surveyed, non-medical switch requests were reported as very frequent or frequent by 35.0% of oncologists (for injectable cancer agents) and up to 80.3% of endocrinologists (for injectable anti-hyperglycemics). Respondents reported decreased medication effectiveness (25.0% of oncologists to 75.0% of dermatologists) and increased side-effects (32.5% of oncologists to 66.7% of psychiatrists). Most specialists reported very frequent or frequent increases in non-office visits (52.5% of oncologists to 75.3% of endocrinologists) and calls with pharmacies (57.5% of oncologists to 80.5% of rheumatologists) due to non-medical switching. <b>Conclusions</b>: Receipt of non-medical switching requests were common among specialist physicians. Non-medical switching may lead to negative effects on patient care and require increased healthcare utilization.</p>","PeriodicalId":73811,"journal":{"name":"Journal of market access & health policy","volume":"8 1","pages":"1738637"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/20016689.2020.1738637","citationCount":"7","resultStr":"{\"title\":\"Specialist physician perspectives on non-medical switching of prescription medications.\",\"authors\":\"Olivia S Costa,&nbsp;Tabassum Salam,&nbsp;Amy Duhig,&nbsp;Aarti A Patel,&nbsp;Ann Cameron,&nbsp;Jennifer Voelker,&nbsp;Brahim Bookhart,&nbsp;Craig I Coleman\",\"doi\":\"10.1080/20016689.2020.1738637\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Introduction</b>: A non-medical switch is a change to a patient's medication regimen for reasons other than lack of clinical response, side-effects or poor adherence. Specialist physicians treat complex patients who may be vulnerable to non-medical switching. <b>Objectives</b>: To evaluate specialist physicians' perceptions regarding the frequency of non-medical switch requests, and the impact on their patients' outcomes and healthcare utilization. <b>Methods</b>: An online survey of randomly sampled physicians spending ≥10% of time providing patient care and having received ≥1 non-medical switch request during the prior 12-months. <b>Results</b>: Among 404 specialist physicians surveyed, non-medical switch requests were reported as very frequent or frequent by 35.0% of oncologists (for injectable cancer agents) and up to 80.3% of endocrinologists (for injectable anti-hyperglycemics). Respondents reported decreased medication effectiveness (25.0% of oncologists to 75.0% of dermatologists) and increased side-effects (32.5% of oncologists to 66.7% of psychiatrists). Most specialists reported very frequent or frequent increases in non-office visits (52.5% of oncologists to 75.3% of endocrinologists) and calls with pharmacies (57.5% of oncologists to 80.5% of rheumatologists) due to non-medical switching. <b>Conclusions</b>: Receipt of non-medical switching requests were common among specialist physicians. Non-medical switching may lead to negative effects on patient care and require increased healthcare utilization.</p>\",\"PeriodicalId\":73811,\"journal\":{\"name\":\"Journal of market access & health policy\",\"volume\":\"8 1\",\"pages\":\"1738637\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/20016689.2020.1738637\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of market access & health policy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/20016689.2020.1738637\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of market access & health policy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/20016689.2020.1738637","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 7

摘要

简介:非医疗转换是指由于缺乏临床反应、副作用或依从性差以外的原因而改变患者的药物治疗方案。专科医生治疗复杂的病人,他们可能容易受到非医疗转换的影响。目的:评估专科医生对非医疗转换请求频率的看法,以及对患者预后和医疗保健利用的影响。方法:对随机抽样的医生进行在线调查,这些医生在过去12个月内花费≥10%的时间为患者提供护理,并且收到≥1次非医疗转换请求。结果:在接受调查的404名专科医生中,35.0%的肿瘤科医生(注射抗癌药物)和高达80.3%的内分泌科医生(注射抗高血糖药物)报告非医疗转换请求非常频繁或频繁。受访者报告药物疗效下降(肿瘤科医生为25.0%,皮肤科医生为75.0%),副作用增加(肿瘤科医生为32.5%,精神科医生为66.7%)。大多数专家报告说,由于非医疗转换,非办公室就诊非常频繁或频繁增加(52.5%的肿瘤科医生对75.3%的内分泌科医生)和药房就诊(57.5%的肿瘤科医生对80.5%的风湿病科医生)。结论:接受非医疗转换请求在专科医生中很常见。非医疗转换可能会对患者护理产生负面影响,并需要增加医疗保健利用率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Specialist physician perspectives on non-medical switching of prescription medications.

Introduction: A non-medical switch is a change to a patient's medication regimen for reasons other than lack of clinical response, side-effects or poor adherence. Specialist physicians treat complex patients who may be vulnerable to non-medical switching. Objectives: To evaluate specialist physicians' perceptions regarding the frequency of non-medical switch requests, and the impact on their patients' outcomes and healthcare utilization. Methods: An online survey of randomly sampled physicians spending ≥10% of time providing patient care and having received ≥1 non-medical switch request during the prior 12-months. Results: Among 404 specialist physicians surveyed, non-medical switch requests were reported as very frequent or frequent by 35.0% of oncologists (for injectable cancer agents) and up to 80.3% of endocrinologists (for injectable anti-hyperglycemics). Respondents reported decreased medication effectiveness (25.0% of oncologists to 75.0% of dermatologists) and increased side-effects (32.5% of oncologists to 66.7% of psychiatrists). Most specialists reported very frequent or frequent increases in non-office visits (52.5% of oncologists to 75.3% of endocrinologists) and calls with pharmacies (57.5% of oncologists to 80.5% of rheumatologists) due to non-medical switching. Conclusions: Receipt of non-medical switching requests were common among specialist physicians. Non-medical switching may lead to negative effects on patient care and require increased healthcare utilization.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.90
自引率
0.00%
发文量
0
审稿时长
14 weeks
期刊最新文献
Comparative Cost Evaluation of Managed Entry Agreement Techniques Using Real-World Data from High-Cost Anticancer Drugs in Thailand. Validation of a De Novo Health Economic Model for Finerenone in Heart Failure with Left Ventricular Ejection Fraction ≥40. Addressing Unmet Medical Needs in Drug Development: Assessment and Implications for Regulatory and Clinical Development Strategies. Can We Trust PAICs in Rare Diseases? Methodological Challenges and Limitations. Structural Enablers of Rare Disease Treatment Coverage in Latin America and the Caribbean: Lessons from Emicizumab.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1